TI
AXSM icon

Trexquant Investment’s Axsome Therapeutics AXSM Stock Holding History

Trexquant Investment’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Buy
83,679
+77,744
+1,310% +$16.9M 0.12% 182
2026
Q1 		$1M Sell
5,935
-43,201
-88% -$7.46M 0.01% 1230
2025
Q4 		$8.97M Buy
49,136
+39,615
+416% +$5.53M 0.08% 352
2025
Q3 		$1.16M Buy
+9,521
New +$1.07M 0.01% 1096
2025
Q1 		– Sell
-14,129
Closed -$1.2M – 1546
2024
Q4 		$1.2M Buy
+14,129
New +$1.3M 0.01% 1042
2023
Q4 		– Sell
-17,450
Closed -$1.22M – 1421
2023
Q3 		$1.22M Buy
+17,450
New +$1.3M 0.03% 672
2023
Q2 		– Sell
-22,732
Closed -$1.4M – 1436
2023
Q1 		$1.4M Sell
22,732
-1,223
-5% -$80.3K 0.04% 590
2022
Q4 		$1.85M Buy
+23,955
New +$1.43M 0.05% 430
2022
Q1 		– Sell
-8,508
Closed -$321K – 1348
2021
Q4 		$321K Buy
8,508
+1,993
+31% +$73.3K 0.02% 879
2021
Q3 		$215K Buy
+6,515
New +$254K 0.02% 922
2020
Q3 		– Sell
-10,102
Closed -$831K – 1188
2020
Q2 		$831K Sell
10,102
-19,018
-65% -$1.46M 0.06% 459
2020
Q1 		$1.71M Buy
29,120
+26,809
+1,160% +$2.18M 0.12% 252
2019
Q4 		$239K Sell
2,311
-14,758
-86% -$596K 0.01% 840
2019
Q3 		$345K Buy
+17,069
New +$439K 0.03% 578
2018
Q1 		– Sell
-22,911
Closed -$128K – 1065
2017
Q4 		$128K Buy
+22,911
New +$116K 0.01% 992

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Trexquant Investment's AXSM Position: Q2 2026 in Review

Trexquant Investment increased its Axsome Therapeutics (AXSM) stake by 1,310% in Q2 2026, buying an estimated $16.9M and bringing the position to 83,679 shares worth $20.5M. The position accounts for 0.12% of the portfolio, ranked #182.

Trexquant Investment first reported a position in AXSM in Q4 2017 and has held it in 15 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Trexquant Investment held 83,679 shares of Axsome Therapeutics worth $20.5M as of Q2 2026.
  • Trexquant Investment bought 77,744 Axsome Therapeutics shares in Q2 2026, an estimated $16.9M.
  • Axsome Therapeutics made up 0.12% of Trexquant Investment's portfolio in Q2 2026, its #182 holding.
  • Trexquant Investment first reported a position in Axsome Therapeutics in Q4 2017 and has held it in 15 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.